NO167533C - Fremgangsmaate ved fremstilling av faktor viii koagulerende polypeptider og monoklonale antistoffer overfor disse. - Google Patents

Fremgangsmaate ved fremstilling av faktor viii koagulerende polypeptider og monoklonale antistoffer overfor disse.

Info

Publication number
NO167533C
NO167533C NO841277A NO841277A NO167533C NO 167533 C NO167533 C NO 167533C NO 841277 A NO841277 A NO 841277A NO 841277 A NO841277 A NO 841277A NO 167533 C NO167533 C NO 167533C
Authority
NO
Norway
Prior art keywords
polypeptides
reacts
factor viii
those
react
Prior art date
Application number
NO841277A
Other languages
English (en)
Norwegian (no)
Other versions
NO841277L (no
NO167533B (no
Inventor
Theodore S Zimmermann
Carol A Fulcher
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27046849&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO167533(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of NO841277L publication Critical patent/NO841277L/no
Publication of NO167533B publication Critical patent/NO167533B/no
Publication of NO167533C publication Critical patent/NO167533C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
NO841277A 1983-03-31 1984-03-30 Fremgangsmaate ved fremstilling av faktor viii koagulerende polypeptider og monoklonale antistoffer overfor disse. NO167533C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48110583A 1983-03-31 1983-03-31
US55650883A 1983-11-30 1983-11-30

Publications (3)

Publication Number Publication Date
NO841277L NO841277L (no) 1984-10-01
NO167533B NO167533B (no) 1991-08-05
NO167533C true NO167533C (no) 1991-11-13

Family

ID=27046849

Family Applications (1)

Application Number Title Priority Date Filing Date
NO841277A NO167533C (no) 1983-03-31 1984-03-30 Fremgangsmaate ved fremstilling av faktor viii koagulerende polypeptider og monoklonale antistoffer overfor disse.

Country Status (12)

Country Link
EP (3) EP0123945B2 (fr)
JP (2) JPH0829089B2 (fr)
AT (2) ATE155490T1 (fr)
AU (1) AU572128B2 (fr)
CA (1) CA1341506C (fr)
DE (2) DE3486453T2 (fr)
DK (2) DK172036B1 (fr)
FI (1) FI841281A (fr)
IE (2) IE80858B1 (fr)
NO (1) NO167533C (fr)
SG (2) SG49675A1 (fr)
ZA (1) ZA842418B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657894A (en) * 1983-03-31 1987-04-14 Scripps Clinic & Research Foundation New factor VIII coagulant polypeptides
US5045455A (en) * 1984-01-12 1991-09-03 Chiron Corporation Factor VIII:C cDNA cloning and expression
US4716117A (en) * 1984-10-26 1987-12-29 Chiron Corporation Monoclonal antibodies to factor VIIIC
DE3583750D1 (de) * 1984-01-12 1991-09-19 Chiron Corp Hybridom-zellinien und monoklonale antikoerper gegen faktor-viii-c.
DK165506C (da) * 1984-01-12 1993-04-19 Chiron Corp Proteinpraeparat med koagulationsaktivitet samt fremgangsmaade til fremstilling deraf
US5004804A (en) * 1984-01-12 1991-04-02 Nordisk Gentofte Method and composition for preparation of factor VIIIC
US7138505B1 (en) 1984-01-12 2006-11-21 Novartis Vaccines And Diagnostics, Inc. Factor VIII:C nucleic acid molecules
US4965199A (en) * 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
FI86885C (fi) * 1984-04-20 1992-10-26 Genentech Inc Foerfarande foer framstaellning av human rekombinantfaktor viii och nukleinsyrasekvenser och vektorer anvaend daertill
SE8501050D0 (sv) * 1985-03-05 1985-03-05 Kabivitrum Ab Biologically active fragments of human antihemophilic factor and method for preparation thereof
KR910006424B1 (ko) * 1985-08-21 1991-08-24 인코텍스 비.브이 편성브리프(brief) 제조방법
JP2593500B2 (ja) * 1986-06-24 1997-03-26 ノルデイスク ゲントフテ エー／エス ▲ｖｉｉｉ▼因子フラグメントの凝固活性複合物の製造方法
CA1339946C (fr) * 1987-03-31 1998-07-07 Michael J. Griffith Methode d'ultrapurification pour les polypeptides
EP0294910B1 (fr) 1987-06-12 1996-09-11 Immuno Ag Protéines à activité de facteur VIII, procédé pour leur production utilisant des cellules modifiées par génie génétique et compositions pharmaceutiques les contenant
IL88309A0 (en) * 1987-11-17 1989-06-30 Scripps Clinic Res Peptides for use in the purification of factor viii
FR2662166A1 (fr) * 1990-05-18 1991-11-22 Fondation Nale Transfusion San Procede de preparation de facteur viii de tres haute purete comprenant une etape rapide d'immunoadsorption.
AU7254894A (en) * 1993-07-23 1995-02-20 Baxter International Inc. Activated human factor viii and method of preparation
US5576291A (en) * 1993-09-13 1996-11-19 Baxter International Inc. Activated factor VIII as a therapeutic agent and method of treating factor VIII deficiency
CN101810854A (zh) 1999-02-22 2010-08-25 巴克斯特国际公司 新的无白蛋白的因子viii制剂
WO2003013244A1 (fr) 2001-08-03 2003-02-20 The Government Of The United State Of America, As Represented By The Secretary Of The Department Of Health And Human Services Traitement de l'hemophilie par voie orale
JP5779780B2 (ja) 2008-11-07 2015-09-16 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 第ｖｉｉｉ因子製剤
BRPI1105317A2 (pt) 2011-01-24 2013-04-30 Fundacco Hemoct De Ribeirco Preto produÇço estÁvel e em larga escala de fviii humano em linhagem celular humana sk-hep-1

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364936A (en) * 1980-01-08 1982-12-21 Ortho Pharmaceutical Corporation Monoclonal antibody to a human monocyte antigen and methods of preparing same
US4364937A (en) * 1980-01-08 1982-12-21 Ortho Pharmaceutical Corporation Monoclonal antibody to a human T cell antigen and methods of preparing same
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4397841A (en) * 1982-06-28 1983-08-09 Monsanto Company Production of blood coagulation factor VIII:C

Also Published As

Publication number Publication date
EP0123945B2 (fr) 2000-04-19
IE80638B1 (en) 1998-10-21
DE3486423T3 (de) 2001-02-08
ZA842418B (en) 1984-11-28
AU572128B2 (en) 1988-05-05
IE960783L (en) 1984-09-30
AU2627284A (en) 1984-10-04
ATE135400T1 (de) 1996-03-15
NO841277L (no) 1984-10-01
CA1341506C (fr) 2006-06-06
EP0123945A1 (fr) 1984-11-07
SG48229A1 (en) 1998-04-17
SG49675A1 (en) 1998-06-15
DE3486453D1 (de) 1997-08-21
JPH0829089B2 (ja) 1996-03-27
EP0770396A2 (fr) 1997-05-02
IE840788L (en) 1984-09-30
FI841281A (fi) 1984-10-01
EP0770396A3 (fr) 1997-07-23
DE3486453T2 (de) 1998-02-26
DK50497A (da) 1997-05-02
DK174984A (da) 1984-10-01
IE80858B1 (en) 1999-04-21
EP0561427A1 (fr) 1993-09-22
ATE155490T1 (de) 1997-08-15
DE3486423T2 (de) 1996-09-19
FI841281A0 (fi) 1984-03-30
DK174984D0 (da) 1984-03-30
DK172036B1 (da) 1997-09-22
DE3486423D1 (de) 1996-04-18
EP0561427B1 (fr) 1997-07-16
JPH0638790A (ja) 1994-02-15
EP0123945B1 (fr) 1996-03-13
JPS59184130A (ja) 1984-10-19
NO167533B (no) 1991-08-05

Similar Documents

Publication Publication Date Title
NO167533C (no) Fremgangsmaate ved fremstilling av faktor viii koagulerende polypeptider og monoklonale antistoffer overfor disse.
IL73883A (en) Monoclonal antibodies against tnf-alpha,hybridomas producing them and method for the purification of tnf-alpha
DE3689734D1 (de) Gereinigter immunoglobulinbezüglicher Faktor, monoklonale Antikörper, Hybridoma-Zellinien, Verfahren und Verwendungen.
EP0212403A3 (fr) Anticorps monoclonaux contre des antigènes humains de différenciation du genre mucine
MY8600514A (en) Monoclonal-antibody-producing hybird cell line, antibody and method of preparing it, therepeutic composition containing it and its diagnostic and therapeutic uses
DE3751908D1 (de) Chimärisches Murine-Mensch-Immunoglobulin, spezifisch für tumorassoziertes 17-1A Antigen
EP0330506A3 (fr) Protéines VLA
GB8806339D0 (en) Monoclonal antibodies
NO843293L (no) Monoklonale antistoffer, samt fremgangsmaate for fremstilling av slike
ATE110084T1 (de) Anticytomegaloviraler menschlicher monoklonaler antikörper und dessen herstellung.
DE3581288D1 (de) Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen.
DE3582358D1 (de) Monoklonaler antikoerper und verfahren zur quantitativen bestimmung von immunoglobulinen mittels dieses antikoerpers.
ES8503371A1 (es) Procedimiento para preparar nuevos anticuerpos de igg de raton con especificidad anti-interferon de humano
KR870004137A (ko) 항인간 인터로이킨 1항체(Anti Hunam Interleukin 1 Antibody)와 그의 제법 및 그의 사용법
Thammana et al. Immunoglobulin heavy chain class switch from IgM to IgG in a hybridoma
ATE62709T1 (de) Monoklonale antikoerper.
KR890016165A (ko) 수도모나스 아에루기노사(Pseudomonas aeruginosa)에 대한 모노클로날 항체, 이의 제조방법 및 용도
AU590688B2 (en) Monoclonal antibody to HLI and its use for purifying HLI
EP0287012A3 (fr) Anticorps monoclonal anti-liant-R, son procédé de préparation et son application
Folds Appearance of a Variant of Mopc 104e Which Does not React with Dextran B-1355s
NO168969C (no) Fremgangsmaate for affinitetsrensing av et hybrid monoklonalt antistoff, fremgangsmaate for dets fremstilling og anvendelse av antistoffet
EP0115063A3 (en) Monoclonal antibody specific for human blood group antigen k (cellano), and hybridoma cell lines producing these monoclonal antibodies
EP0349258A3 (fr) Procédé pour déterminer la différentiation d'une cellule-T humaine
BG46674A1 (en) Hybridom cell line mus musculus vsp- 1e7 secreting monoclonal antibodies against virus of classical plague
NZ228194A (en) Monoclonal antibodies which bind to the n-terminal peptide sequence of the betasubunit of human haemoglobiin

Legal Events

Date Code Title Description
MK1K Patent expired